Ginkgo Bioworks (DNA) Stock: Buy, Sell, or Hold?
DNA - Ginkgo Bioworks Holdings, Inc.
$12.35
-0.15 (-1.20%)
▼
5d:
+15.85%
30d:
+75.68%
90d:
+22.16%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 05, 2026
Get Alerted When DNA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: DNA is 19.8% above its trading range ($10.31). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: DNA is 19.8% above its trading range ($10.31). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: DNA is currently trading at $12.35, which is considered extended relative to its 30-day fair value range of $6.34 to $10.31.
Technical Outlook: Technically, DNA is in a strong uptrend. Immediate support is located at $7.67, while resistance sits at $13.41.
Market Sentiment: DNA scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $7.00. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, DNA is in a strong uptrend. Immediate support is located at $7.67, while resistance sits at $13.41.
Market Sentiment: DNA scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $7.00. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$6.34 -
$10.31
Company Quality Score
35/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
5.3%
Protect Your Profits
DNA is technically overbought (RSI 75). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+19.8% above its trading range)
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 43.3% above Wall St target ($7.00)
- WARNING: Composite score 35/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$6.34 -
$10.31
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$7.67
Resistance Level
$13.42
Current Trend
Strong Uptrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.26
Wall Street Target
$7.00
(-43.3%)
Revenue Growth (YoY)
-48.5%
Profit Margin
-219.6%
Share & Embed Analysis
Last updated: October 03, 2026 1:11 PM ET
Data refreshes hourly during market hours. Next update: 2:11 PM
Data refreshes hourly during market hours. Next update: 2:11 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DNA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
10
Sells
Net
INSIDERS SELLING
Recent Transactions
Steven P Coen
SELL
324 shares
2026-04-17
Steven P Coen
SELL
33171 shares
2026-04-13
Barry Canton
SELL
124727 shares
2026-04-10
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 49 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1180 | 52 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$47 | 46 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$851 | 48 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$293 | 67 BUY |
Advanced DNA Option Strategies
Professional options setups generated by AI based on today's DNA price and gamma walls.
